Evidence map›Paper›PMID 33216133›Full record

ArticleThe Journal of infectious diseases2021

Genetic Background Amplifies the Effect of Immunodeficiency in Antibiotic Efficacy Against Borrelia burgdorferi.

Bijaya Sharma, Julie E McCarthy, Cecily A Freliech, Morgen M Clark, Linden T Hu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Persistent Borrelia burgdorferiClinical microbiology reviews · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Bijaya SharmaDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Julie E McCarthyDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Cecily A FreliechDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Morgen M ClarkDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Linden T HuDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Tufts University · USBrigham and Women's Hospital · USMichigan State University · US

Funding

Development and Field Testing of a Novel Reservoir Targeted Antibiotic Against Borrelia burgdorferiR01AI152210 · NIAID · TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T, LEWIS, KIM · 2020 to 2025
$3.9M
Persister cells of Borrelia burgdorferiR01AI122286 · NIAID · NORTHEASTERN UNIVERSITY · PI HU, LINDEN T, LEWIS, KIM · 2016 to 2019
$2.3M
Role of innate immune tolerance in the pathogenesis of Lyme diseaseR21AI126757 · NIAID · TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T · 2016 to 2017
$454k
NIAID NIH HHS R01 AI122286NIAID NIH HHS R01 AI152210NIAID NIH HHS R21 AI126757
6 · The paper itself

Abstract

Unrecognized immunodeficiency has been proposed as a possible cause of failure of antibiotics to resolve symptoms of Lyme disease. Here, we examined the efficacy of doxycycline in different immunodeficient mice to identify defects that impair antibiotic treatment outcomes. We found that doxycycline had significantly lower efficacy in the absence of adaptive immunity, specifically B cells. This effect was most pronounced in immunodeficient C3H mice compared with C57BL/6 mice, suggesting a role for genetic background beyond immunodeficiency. Addition of a single dose of ceftriaxone to doxycycline treatment effectively cleared infection in C3H mice with severe combined immunodeficiency.

Indexed as

Anti-Bacterial AgentsGenetic BackgroundImmunologic Deficiency SyndromesLyme DiseaseAnimalsBorrelia burgdorferiDoxycyclineMiceMice, Inbred C3HMice, Inbred C57BLAnti-Bacterial AgentsDoxycyclineantibioticsBorrelia burgdorferiLyme disease

Identifiers

PMID33216133
PMCPMC8280483
OpenAlexW3100641375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.